Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of etravirine levels in seminal plasma in subjects infected with HIV
2011-001463-51Phase 4Completed
- Sponsor
- Bellvitge University Hospital
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of etravirine in human immunodeficiency virus infection (HIV), sponsored by Bellvitge University Hospital. Primary endpoint: Pharmacologic concentration of etravirine in semen and plasma. Started Sep 2011; status: completed.
02
Drugs
etravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2011-001463-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001463-51.